These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 25819332)

  • 1. Nucleobase modified neamines with a lysine as a linker, their inhibition specificity for TAR-Tat derived from HIV-1.
    Inoue R; Watanabe K; Katou T; Ikezawa Y; Hamasaki K
    Bioorg Med Chem; 2015 May; 23(9):2139-47. PubMed ID: 25819332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nucleobase modified neamines, their synthesis and binding specificity for HIV TAR RNA.
    Watanabe K; Katou T; Ikezawa Y; Yajima S; Shionoya H; Akagi T; Hamasaki K
    Nucleic Acids Symp Ser (Oxf); 2007; (51):209-10. PubMed ID: 18029660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neamine derivatives having a nucleobase with a lysine or an arginine as a linker, their synthesis and evaluation as potential inhibitors for HIV TAR-Tat.
    Yajima S; Shionoya H; Akagi T; Hamasaki K
    Bioorg Med Chem; 2006 Apr; 14(8):2799-809. PubMed ID: 16413787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neamine dimers targeting the HIV-1 TAR RNA.
    Riguet E; Désiré J; Boden O; Ludwig V; Göbel M; Bailly C; Décout JL
    Bioorg Med Chem Lett; 2005 Nov; 15(21):4651-5. PubMed ID: 16153833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular dynamics and MM/GBSA-integrated protocol probing the correlation between biological activities and binding free energies of HIV-1 TAR RNA inhibitors.
    Peddi SR; Sivan SK; Manga V
    J Biomol Struct Dyn; 2018 Feb; 36(2):486-503. PubMed ID: 28081678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding of neomycin to the TAR element of HIV-1 RNA induces dissociation of Tat protein by an allosteric mechanism.
    Wang S; Huber PW; Cui M; Czarnik AW; Mei HY
    Biochemistry; 1998 Apr; 37(16):5549-57. PubMed ID: 9548939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis, and biological evaluation of novel quinoline derivatives as HIV-1 Tat-TAR interaction inhibitors.
    Chen S; Chen R; He M; Pang R; Tan Z; Yang M
    Bioorg Med Chem; 2009 Mar; 17(5):1948-56. PubMed ID: 19217787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 2-Phenylquinolones as inhibitors of the HIV-1 Tat-TAR interaction.
    Gatto B; Tabarrini O; Massari S; Giaretta G; Sabatini S; Del Vecchio C; Parolin C; Fravolini A; Palumbo M; Cecchetti V
    ChemMedChem; 2009 Jun; 4(6):935-8. PubMed ID: 19283692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Probing interaction of a fluorescent ligand with HIV TAR RNA.
    Qi L; Zhang J; He T; Huo Y; Zhang ZQ
    Spectrochim Acta A Mol Biomol Spectrosc; 2017 Feb; 173():93-98. PubMed ID: 27611591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of neomycin analogues for HIV-1 RRE RNA recognition identifies enhanced activity simplified neamine analogues.
    Simon B; Walmsley C; Jackson VJ; Garvey EP; Slater MJ; Berrisford DJ; Gardiner JM
    Bioorg Med Chem Lett; 2019 Jan; 29(2):339-341. PubMed ID: 30477891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural rearrangements of HIV-1 Tat-responsive RNA upon binding of neomycin B.
    Faber C; Sticht H; Schweimer K; Rösch P
    J Biol Chem; 2000 Jul; 275(27):20660-6. PubMed ID: 10747964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and evaluation of novel neamine derivatives effectively targeting to RNA.
    Xu Y; Jin H; Yang Z; Zhang L; Wang Q; Li M; Zhang L
    Bioorg Med Chem Lett; 2009 Apr; 19(8):2103-6. PubMed ID: 19327991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Orientation and affinity of HIV-1 Tat fragments in Tat-TAR complex determined by fluorescence resonance energy transfer.
    Cao H; Tamilarasu N; Rana TM
    Bioconjug Chem; 2006; 17(2):352-8. PubMed ID: 16536465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A peptide nucleic acid-neamine conjugate that targets and cleaves HIV-1 TAR RNA inhibits viral replication.
    Riguet E; Tripathi S; Chaubey B; Désiré J; Pandey VN; Décout JL
    J Med Chem; 2004 Sep; 47(20):4806-9. PubMed ID: 15369382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and synthesis of a novel peptidomimetic inhibitor of HIV-1 Tat-TAR interactions: squaryldiamide as a new potential bioisostere of unsubstituted guanidine.
    Lee CW; Cao H; Ichiyama K; Rana TM
    Bioorg Med Chem Lett; 2005 Oct; 15(19):4243-6. PubMed ID: 16054360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alpha,alpha-trehalose derivatives bearing guanidino groups as inhibitors to HIV-1 Tat-TAR RNA interaction in human cells.
    Wang M; Xu Z; Tu P; Yu X; Xiao S; Yang M
    Bioorg Med Chem Lett; 2004 May; 14(10):2585-8. PubMed ID: 15109657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluorescence correlation spectroscopy at single molecule level on the Tat-TAR complex and its inhibitors.
    Nandi CK; Parui PP; Brutschy B; Scheffer U; Göbel M
    Biopolymers; 2008 Jan; 89(1):17-25. PubMed ID: 17764074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tripeptides from synthetic amino acids block the Tat-TAR association and slow down HIV spread in cell cultures.
    Ludwig V; Krebs A; Stoll M; Dietrich U; Ferner J; Schwalbe H; Scheffer U; Dürner G; Göbel MW
    Chembiochem; 2007 Oct; 8(15):1850-6. PubMed ID: 17886825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitors of protein-RNA complexation that target the RNA: specific recognition of human immunodeficiency virus type 1 TAR RNA by small organic molecules.
    Mei HY; Cui M; Heldsinger A; Lemrow SM; Loo JA; Sannes-Lowery KA; Sharmeen L; Czarnik AW
    Biochemistry; 1998 Oct; 37(40):14204-12. PubMed ID: 9760258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of N-acetylation and N-methylation of lysine residue of Tat peptide on its interaction with HIV-1 TAR RNA.
    Kumar S; Maiti S
    PLoS One; 2013; 8(10):e77595. PubMed ID: 24147034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.